REGN logo

REGN
Regeneron Pharmaceuticals, Inc.

17,588
Mkt Cap
$80.53B
Volume
1M
52W High
$821.11
52W Low
$476.49
PE Ratio
18.33
REGN Fundamentals
Price
$761.85
Prev Close
$777.25
Open
$767.04
50D MA
$765.50
Beta
0.63
Avg. Volume
603,688.36
EPS (Annual)
$41.48
P/B
2.58
Rev/Employee
$930,752.76
$78,186.98
Loading...
Loading...
News
all
press releases
Regeneron Pharmaceuticals, Inc. $REGN Shares Bought by Allspring Global Investments Holdings LLC
Allspring Global Investments Holdings LLC grew its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 40.1% in the 4th quarter, according to its most recent Form 13F...
MarketBeat·7h ago
News Placeholder
More News
News Placeholder
Best Pharmaceutical Stocks To Follow Today - April 3rd
Eli Lilly and Company, AbbVie, Bristol Myers Squibb, Pfizer, Regeneron Pharmaceuticals, Gilead Sciences, and Terns Pharmaceuticals are the seven Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies that re...
MarketBeat·20h ago
News Placeholder
Will Regeneron (REGN) Beat Estimates Again in Its Next Earnings Report?
Regeneron (REGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks·22h ago
News Placeholder
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Zacks·1d ago
News Placeholder
Aberdeen Group plc Has $124.84 Million Holdings in Regeneron Pharmaceuticals, Inc. $REGN
Aberdeen Group plc raised its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 6.8% during the 4th quarter, according to the company in its most recent 13F filing...
MarketBeat·1d ago
News Placeholder
TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions
TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions...
PR Newswire·2d ago
News Placeholder
Bayer Advances AB-1002 Study, Highlights Pharma Growth Strategy
Bayer advances AB-1002 after AskBio completes mid-stage study enrollment, as its Pharma strategy and pipeline milestones drive long-term growth outlook.
Zacks·2d ago
News Placeholder
Moody Lynn & Lieberson LLC Purchases New Position in Regeneron Pharmaceuticals, Inc. $REGN
Moody Lynn & Lieberson LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) during the fourth quarter, according to the company in its most recent...
MarketBeat·3d ago
News Placeholder
Bayer Wins EC Approval to Expand Kerendia in Heart Failure Treatment
Bayer wins EU nod to expand Kerendia's use in heart failure, backed by strong phase III data, boosting a key drug driving growth and portfolio momentum.
Zacks·4d ago
News Placeholder
Is ANIP Undervalued? How to Read Its 9.3x Forward P/E
ANI Pharmaceuticals trades at just 9.3x forward earnings, far below peers - raising a key question: is this a bargain or a signal of execution risks ahead?
Zacks·4d ago
<
1
2
...
>

Latest REGN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.